Sovrin supply the Relenza dry powder inhaler (DPI) to one of the leading pharmaceutical companies. Their main criteria was to scale up high volume validated production in the shortest possible time. This meant that a bespoke production cell needed to be designed and built from scratch. High quality was engineered in, right from the beginning. The device is also sold to the Japanese market.